Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.

Kirov II, Tal A, Babb JS, Herbert J, Gonen O.

Neurology. 2013 Jan 1;80(1):39-46. doi: 10.1212/WNL.0b013e31827b1a8c.

2.

Diffuse axonal injury in mild traumatic brain injury: a 3D multivoxel proton MR spectroscopy study.

Kirov II, Tal A, Babb JS, Lui YW, Grossman RI, Gonen O.

J Neurol. 2013 Jan;260(1):242-52. doi: 10.1007/s00415-012-6626-z.

3.

MR spectroscopy indicates diffuse multiple sclerosis activity during remission.

Kirov II, Patil V, Babb JS, Rusinek H, Herbert J, Gonen O.

J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1330-6. doi: 10.1136/jnnp.2009.176263.

4.
5.

Proton MR spectroscopy correlates diffuse axonal abnormalities with post-concussive symptoms in mild traumatic brain injury.

Kirov II, Tal A, Babb JS, Reaume J, Bushnik T, Ashman TA, Flanagan S, Grossman RI, Gonen O.

J Neurotrauma. 2013 Jul 1;30(13):1200-4. doi: 10.1089/neu.2012.2696.

6.

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.

Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, McLean MA, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH.

J Neurol. 2006 Feb;253(2):224-30.

PMID:
16307201
7.

Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.

Kirov II, Liu S, Fleysher R, Fleysher L, Babb JS, Herbert J, Gonen O.

Radiology. 2010 Mar;254(3):858-66. doi: 10.1148/radiol.09091015.

8.

Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.

Inglese M, Li BS, Rusinek H, Babb JS, Grossman RI, Gonen O.

Magn Reson Med. 2003 Jul;50(1):190-5.

9.

Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.

Pascual AM, Martínez-Bisbal MC, Boscá I, Valero C, Coret F, Martínez-Granados B, Marti-Bonmati L, Mir A, Celda B, Casanova B.

Neurology. 2007 Jul 3;69(1):63-7.

PMID:
17606882
10.

Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.

Chard DT, Griffin CM, McLean MA, Kapeller P, Kapoor R, Thompson AJ, Miller DH.

Brain. 2002 Oct;125(Pt 10):2342-52.

11.

Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients.

Wu WE, Kirov II, Tal A, Babb JS, Milla S, Oved J, Weiner HL, Devinsky O, Gonen O.

Epilepsy Behav. 2013 May;27(2):319-25. doi: 10.1016/j.yebeh.2013.02.018.

12.

Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis.

Oguz KK, Kurne A, Aksu AO, Karabulut E, Serdaroglu A, Teber S, Haspolat S, Senbil N, Kurul S, Anlar B.

AJNR Am J Neuroradiol. 2009 Apr;30(4):716-21. doi: 10.3174/ajnr.A1425.

13.

Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.

Hannoun S, Bagory M, Durand-Dubief F, Ibarrola D, Comte JC, Confavreux C, Cotton F, Sappey-Marinier D.

PLoS One. 2012;7(3):e32525. doi: 10.1371/journal.pone.0032525. Erratum in: PLoS One. 2012;7(8): doi/10.1371/annotation/beed29e2-e61a-4d2f-8baa-ac53cf2fee7b.

14.

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS, Antel JP, Wolfson C, Arnold DL.

Brain. 1998 Jan;121 ( Pt 1):103-13.

15.
16.

White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.

Kendall GS, Melbourne A, Johnson S, Price D, Bainbridge A, Gunny R, Huertas-Ceballos A, Cady EB, Ourselin S, Marlow N, Robertson NJ.

Radiology. 2014 Apr;271(1):230-8. doi: 10.1148/radiol.13122679.

PMID:
24475798
17.

Global gray and white matter metabolic changes after simian immunodeficiency virus infection in CD8-depleted rhesus macaques: proton MRS imaging at 3 T.

Wu WE, Tal A, Kirov II, Rusinek H, Charytonowicz D, Babb JS, Ratai EM, Gilberto Gonzalez R, Gonen O.

NMR Biomed. 2013 Apr;26(4):480-8. doi: 10.1002/nbm.2889.

18.

Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.

Adalsteinsson E, Langer-Gould A, Homer RJ, Rao A, Sullivan EV, Lima CA, Pfefferbaum A, Atlas SW.

AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1941-5.

19.

Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS : a MRSI study.

Van Au Duong M, Audoin B, Le Fur Y, Confort-Gouny S, Malikova I, Soulier E, Viout P, Ali-Cherif A, Pelletier J, Cozzone PJ, Ranjeva JP.

J Neurol. 2007 Jul;254(7):914-23.

PMID:
17446993
20.

Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.

Auer DP, Schirmer T, Heidenreich JO, Herzog J, Pütz B, Dichgans M.

Neurology. 2001 Mar 13;56(5):635-42.

PMID:
11245716
Items per page

Supplemental Content

Support Center